|
US2014127816A1
|
|
Facultatively attenuated bacterial species and methods of preparation and use thereof
|
|
KR20150022996A
|
|
Compositions and methods for cancer immunotherapy
|
|
WO2012068360A1
|
|
Methods and compositions for inducing an immune response to egfrviii
|
|
CA2814176A1
|
|
Methods and compositions for inducing a t-cell response to plasmodium species
|
|
CN102149406A
|
|
Compositions and methods for the treatment of hepatitis c
|
|
CN102076843A
|
|
Compositions comprising prfa*mutant listeria and methods of use thereof
|
|
CN101951890A
|
|
Thermotherapy sensor that part is puted together and preparation method thereof
|
|
US2007207170A1
|
|
Engineered Listeria and methods of use thereof
|
|
US2006142749A1
|
|
Magnetic nanoscale particle compositions, and therapeutic methods related thereto
|
|
US2005249748A1
|
|
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
US2010068230A1
|
|
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
AU2004224425A1
|
|
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
AU2004246999A1
|
|
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
|
|
CN1758923A
|
|
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria
|
